Selander D, Dhuner KG, Lundborg G. Peripheral nerve injury due to injection needles used for regional anesthesia. An experimental study of the acute effects of needle point trauma. Acta Anaesthesiol Scand. 1977. 21(3):182-8. [Medline].
Czervionke LF, Fenton DS. Basic needle manipulation techniques. Czervionke LF, Fenton DS, eds. Image-Guided Spine Intervention. Philadelphia: Saunders: 2003. 1-8:
Mayo NA, Fadale PD. The role of injectable corticosteroids in orthopedics. Orthop. 2001. 24:400-5.
Sitzman BT. Pharmacology for the spine injectionist. Fenton DS, Czervionke LF, eds. Image-guided spine intervention. Philadelphia: Saunders; 2003. 287-92.
Schimmer BP, Parker KL. Adrenocortical steroids. Hardman JG, Gilman AG, Limbird LE. Goodman and Gilman's The pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill; 1996. 1465-81.
Wiggins ME, Fadale PD, Barrach H, Ehrlich MG, Walsh WR. Healing characteristics of a type I collagenous structure treated with corticosteroids. Am J Sports Med. 1994 Mar-Apr. 22(2):279-88. [Medline].
Cohen IK, Diegelmann RF, Johnson ML. Effect of corticosteroids on collagen synthesis. Surgery. 1977 Jul. 15-20:82(1). [Medline].
Bogduk N. Complications associated with transforaminal injections. Neal JM, Rathmell JP. Complications in Regional Anesthesia and Pain Medicine. Philadelphia, Pa: Saunders; 2007. 259-265.
Dreyer SJ. Commonly used medications in pain procedures. Lennard JA, ed. Pain procedures in clinical practice. Philadelphia, Pa: Hanley & Belfus; 2000. 1-9.
Benzon HT. Fluoroscopy and Radiation Safety, Essentials of Pain Medicine and Regional Anesthesia. Philadelphia: Elsevier Churchill Livingston; 2005. 516-24.
Machikanti L, Bakhit CE, Fellowes B:. Fluoroscopy is medically necessary for the performance of epidural steroids. Anesthes Analg. 1999. 89:1330-31.
Fishman SM, Smith H, Meleger A, Seibert JA. Radiation safety in pain medicine. Reg Anesth Pain Med. 2002 May-Jun. 27(3):296-305. [Medline].
Broadman L. Radiation Safety. Raj PP, Abram BM, Benzin HT. Practical Management of Pain. 2. St Louis: Mosby; 2000. 834-837.
Gruber RD, Botwin KP, Chunila SP. Radiation safety for the physician. Leonard TA, ed. Pain Procedures in Clinical Practice. 2nd ed. Hanley & Belfast; 2000. 25-32.
[Guideline] Boswell MV, Trescott AM, Datta S, Schultz DM, et al. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician. 2007. 10(1):7-111. [Medline].
Manchikanti L, Staats PS, Singh V, Schultz DM, Vilims BD, Jasper JF, et al. Evidence-based practice guidelines for interventional techniques in the management of chronic spinal pain. Pain Physician. 2003 Jan. 6(1):3-81. [Medline].
Ghai B, Vadaje KS, Wig J, Dhillon MS. Lateral Parasagittal Versus Midline Interlaminar Lumbar Epidural Steroid Injection for Management of Low Back Pain with Lumbosacral Radicular Pain: A Double-Blind, Randomized Study. Anesth Analg. 2013 Apr 30. [Medline].
Pinto RZ, Maher CG, Ferreira ML, Hancock M, Oliveira VC, McLachlan AJ, et al. Epidural corticosteroid injections in the management of sciatica: a systematic review and meta-analysis. Ann Intern Med. 2012 Dec 18. 157(12):865-77. [Medline].
Waldman SD. Atlas of Interventional Pain Management. Philadelphia, PA: Elsevier; 2004.
Loeser JD, Butler SH, Chapman RC, Turk DC, eds. Bonica’s Management of Pain. Philadelphia, PA: Lippencott, Williams & Wilkins; 2001.
Manchikanti L, Singh V, eds. Interventional Techniques in Chronic Spinal Pain. Paducah, KY: ASSIP Publishing; 2007.
Castagnera L, Maurette P, Pointillart V, et al. Long-term results of cervical epidural steroid injection with and without morphine in chronic cervical radicular pain. Pain. 1994 Aug. 58(2):239-43. [Medline].
Stav A, Ovadia L, Sternberg A, Kaadan M, Weksler N. Cervical epidural steroid injection for cervicobrachialgia. Acta Anaesthesiol Scand. 1993 Aug. 37(6):562-6. [Medline].
Fenton S, Czervionke, eds. Image-guided Spine Intervention. Philadelphia, PA: Elsevier; 2003.
Settler PE. Therapeutic use of botulinum toxins: background and history. Clin J Pain. 2002. 18:S19-24.
Evans DM, Williams RS, Shone CC, et al. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Eur J Biochem. 1986 Jan 15. 154(2):409-16. [Medline].
Simpson LL. Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction. J Pharmacol Exp Ther. 1980 Jan. 212(1):16-21. [Medline].
Tsui JK. Botulinum toxin as a therapeutic agent. Pharmacol Ther. 1996. 72:13-24.
Lew MF. Review of the FDA-approved uses of botulinum toxins, including data suggesting efficacy in pain reduction. Clin J Pain. 2002 Nov-Dec. 18(6 Suppl):S142-6. [Medline].
Jurasinski CV, Lieth E, Dang Do AN, Schengrund CL. Correlation of cleavage of SNAP-25 with muscle function in a rat model of Botulinum neurotoxin type A induced paralysis. Toxicon. 2001 Sep. 39(9):1309-15. [Medline].
Meunier FA, Schiavo G, Molgo J. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission. J Physiol Paris. 2002 Jan-Mar. 96(1-2):105-13. [Medline].
Simpson LL. Identification of the characteristics that underlie botulinum toxin potency: implications for designing novel drugs. Biochimie. 2000 Sep-Oct. 82(9-10):943-53. [Medline].
Guyer BM. Mechanism of Botulinum Toxin in the Relief of Chronic Pain. Curr Rev Pain. 1999. 3(6):427-431. [Medline].
Hallet M. How does botulinum toxin work?. Ann Neurol. 2000. 48:7-8.
Gobel H, Heinze A, Heinze-Kuhn K, Austermann K. Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes. Pain. 2001 Apr. 91(3):195-9. [Medline].
Borodic GE, Acquadro M, Johnson EA. Botulinum toxin therapy for pain and inflammatory disorders: mechanisms and therapeutic effects. Expert Opin Investig Drugs. 2001 Aug. 10(8):1531-44. [Medline].
Aoki KR. Evidence for antinociceptive activity of botulinum toxin type A in pain management. Headache. 2003 Jul-Aug. 43 Suppl 1:S9-15. [Medline].
Cui ML, Khanijou S, Rubino J, et al. Botulinum toxin A inhibits the inflammatory pain in the rat formalin model. Soc Neurosci Abst. 2000. 26:656:
Cui M, Li Z, You S. Mechanisms of the antinociceptive effect of subcutaneous BOTOX: inhibition of peripheral and central nociceptive processing. Arch Pharnacol. 2002. 365:33:
Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005 Oct. 26(5):785-93. [Medline].
Simons DG. Clinical and etiological update of myofascial pain from trigger points. Clinical Overview and Pathogenesis of Fibromyalgia Syndrome, Myofascial Pain. 1996. 93-122.
Cheshire WP, Abashian SW, Mann JD. Botulinum toxin in the treatment of myofascial pain syndrome. Pain. 1994 Oct. 59(1):65-9. [Medline].
Wheeler AH, Goolkasian P, Gretz SS. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine. 1998 Aug 1. 23(15):1662-6; discussion 1667. [Medline].
Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache. 1998 Jun. 38(6):468-71. [Medline].
Simons DG, Travell JG. Travell and Simons’ myofascial pain and dysfunction: the trigger point manual. 2nd ed. Baltimore, MD: Williams & Wilkins; 1999.
Lang A. A pilot study of botulinum toxin type A (BOTOX), administered using a novel injection technique, for the treatment of myofascial pain. Am J Pain Manage. 2000. 10:108-12.
Ferrante M, Bearn L, Rothrock R, King L. Botulinum toxin type A in the treatment of myofascial pain. Presented at the annual meeting of the American Society of Anesthesiologists, 2002.
Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain. 2000 Mar. 85(1-2):101-5. [Medline].
Opida C. Open-label study of Myobloc (botulinum toxin type B) in the treatment of patients with transformed migraine headaches. [abstract] J Pain 2002a;3(Suppl 1):10.
Taqi D, Gunyea I, Bhakta B, et al. Botulinum toxin type A (BOTOX) in the treatment of refractory cervicothoracic myofascial pain. [abstract]. Pain. 2002. 3(suppl 1):16.
Taqi D, Royal M, Gunyea I, et al. Botulinum toxin type B (Myobloc) in the treatment of refractory myofascial pain. [abstract]. Pain. 2002. 3(suppl 1):16.
Fishman LM. Myobloc in the treatment of piriformis syndrome: a dose finding study. Presented at the American Academy of Pain Medicine’s annual meeting. San Francisco, CA, 2002.
Nalamachu S. Treatment with botulinum toxin type B (Myobloc) injections in three patients with myofascial pain. Presented at the American Academy of Pain Medicine’s annual scientific meeting. San Francisco, CA, 2002.
Smith H, Audette J, Dey R, et al. Botulinum toxin type B for a patient with myofascial pain. Presented at the American Academy of Pain Medicine’s annual scientific meeting. San Francisco, CA, 2002.
Lang AM. Botulinum toxin therapy for myofascial pain disorders. Curr Pain Headache Rep. 2002 Oct. 6(5):355-60. [Medline].
Sheean G. Botulinum toxin for the treatment of musculoskeletal pain and spasm. Curr Pain Headache Rep. 2002 Dec. 6(6):460-9. [Medline].
De Andres J, Adsuara VM, Palmisani S, Villanueva V, Lopez-Alarcon MD. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans. Reg Anesth Pain Med. 2010 May-Jun. 35(3):255-60. [Medline].
Saenz A, Avellanet M, Garreta R. Use of botulinum toxin type A on orthopedics: a case report. Arch Phys Med Rehabil. 2003 Jul. 84(7):1085-6. [Medline].
Childers MK, Wilson DJ, Gnatz SM, Conway RR, Sherman AK. Botulinum toxin type A use in piriformis muscle syndrome: a pilot study. Am J Phys Med Rehabil. 2002 Oct. 81(10):751-9. [Medline].
Fanucci E, Masala S, Sodani G, et al. CT-guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process. Eur Radiol. 2001. 11(12):2543-8. [Medline].
Fishman LM, Anderson C, Rosner B. BOTOX and physical therapy in the treatment of piriformis syndrome. Am J Phys Med Rehabil. 2002 Dec. 81(12):936-42. [Medline].
Gobel H, Heinze A, Reichel G, Hefter H, Benecke R. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study. Pain. 2006 Nov. 125(1-2):82-8. [Medline].
Lew HL, Lee EH, Castaneda A, Klima R, Date E. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study. Arch Phys Med Rehabil. 2008 Jan. 89(1):75-80. [Medline].
Padberg M, de Bruijn SF, Tavy DL. Neck pain in chronic whiplash syndrome treated with botulinum toxin. A double-blind, placebo-controlled clinical trial. J Neurol. 2007 Mar. 254(3):290-5. [Medline].
Carroll A, Barnes M, Comiskey C. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder. Clin Rehabil. 2008 Jun. 22(6):513-9. [Medline].
Braker C, Yariv S, Adler R, Badarny S, Eisenberg E. The analgesic effect of botulinum-toxin A on postwhiplash neck pain. Clin J Pain. 2008 Jan. 24(1):5-10. [Medline].
Miller D, Richardson D, Eisa M, Bajwa RJ, Jabbari B. Botulinum neurotoxin-A for treatment of refractory neck pain: a randomized, double-blind study. Pain Med. 2009 Sep. 10(6):1012-7. [Medline].
Foster L, Clapp L, Erickson M, Jabbari B. Botulinum toxin A and chronic low back pain: a randomized, double-blind study. Neurology. 2001 May 22. 56(10):1290-3. [Medline].
Knusel B, DeGryse R, Grant M, et al. Intramuscular injection of botulinum toxin type A (BOTOX) in chronic low back pain associated with muscle spasm. Presented at the American Pain Society annual scientific meeting. San Diego, CA, 1998.
Jabbari B. Botulinum neurotoxins in the treatment of refractory pain. Nat Clin Pract Neurol. 2008 Dec. 4(12):676-85. [Medline].
Jabbari B, Ney J, Sichani A, Monacci W, Foster L, Difazio M. Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study. Pain Med. 2006 May-Jun. 7(3):260-4. [Medline].
Ney JP, Difazio M, Sichani A, Monacci W, Foster L, Jabbari B. Treatment of chronic low back pain with successive injections of botulinum toxin a over 6 months: a prospective trial of 60 patients. Clin J Pain. 2006 May. 22(4):363-9. [Medline].
Wheeler AH. Botulinum toxin A for the treatment of neuropathic pain. ;. AJPM. 2004. 14:151-6.
Freund B, Schwartz M. Subcutaneous BTX-A in the treatment of neuropathic pain: a pilot study. Presented at the 38th Interagency Botulism Research Coordinating Committee Meeting, Easton, (MD) October 17-19:2001.
Jabbari B, Maher N, Difazio MP. Botulinum toxin a improved burning pain and allodynia in two patients with spinal cord pathology. Pain Med. 2003 Jun. 4(2):206-10. [Medline].
Shealy CN. Dangers of spinal injections without proper diagnosis. JAMA. 1966 Sep 26. 197(13):1104-6. [Medline].
Lackovic Z, Bach-Rojecky L, Salcovic-Petrisic M. Antinociceptive effect of botulinum toxin type A in experimental diabetic neuropathy [abstract P06.188]. Presented at the American Academy of Neurology’s 58th Annual Meeting, San Diego, CA, April 1-8, 2006.
Relja M, Militec Z. Botulinum toxin type-A in the treatment of painful diabetic neuropathy: a prospective study [abstract S07.006]. Presented at the American Academy of Neurology’s 58th Annual Meeting, San Diego, CA, April 1-8, 2006.
Mahowald ML, Singh JA, Dykstra D. Long term effects of intra-articular botulinum toxin A for refractory joint pain. Neurotox Res. 2006 Apr. 9(2-3):179-88. [Medline].
Singh JA, Fitzgerald PM. Botulinum toxin for shoulder pain. Cochrane Database Syst Rev. 2010 Sep 8. CD008271. [Medline].
Babcock MS, Foster L, Pasquina P, Jabbari B. Treatment of pain attributed to plantar fasciitis with botulinum toxin a: a short-term, randomized, placebo-controlled, double-blind study. Am J Phys Med Rehabil. 2005 Sep. 84(9):649-54. [Medline].
Yelnik AP, Colle FM, Bonan IV, Vicaut E. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A. J Neurol Neurosurg Psychiatry. 2007 Aug. 78(8):845-8. [Medline].
Kong KH, Neo JJ, Chua KS. A randomized controlled study of botulinum toxin A in the treatment of hemiplegic shoulder pain associated with spasticity. Clin Rehabil. 2007 Jan. 21(1):28-35. [Medline].
Marco E, Duarte E, Vila J, Tejero M, Guillen A, Boza R. Is botulinum toxin type A effective in the treatment of spastic shoulder pain in patients after stroke? A double-blind randomized clinical trial. J Rehabil Med. 2007 Jul. 39(6):440-7. [Medline].
de Boer KS, Arwert HJ, de Groot JH, Meskers CG, Mishre AD, Arendzen JH. Shoulder pain and external rotation in spastic hemiplegia do not improve by injection of botulinum toxin A into the subscapular muscle. J Neurol Neurosurg Psychiatry. 2008 May. 79(5):581-3. [Medline].
Lim JY, Koh JH, Paik NJ. Intramuscular botulinum toxin-A reduces hemiplegic shoulder pain: a randomized, double-blind, comparative study versus intraarticular triamcinolone acetonide. Stroke. 2008 Jan. 39(1):126-31. [Medline].
Singh JA, Fitzgerald PM. Botulinum Toxin for Shoulder Pain: A Cochrane Systematic Review. J Rheumatol. 2011 Feb 1. [Medline].
Wissel J, Muller J, Dressnandt J, Heinen F, Naumann M, Topka H. Management of spasticity associated pain with botulinum toxin A. J Pain Symptom Manage. 2000 Jul. 20(1):44-9. [Medline].
Zermann D, Ishigooka M, Schubert J, Schmidt RA. Perisphincteric injection of botulinum toxin type A. A treatment option for patients with chronic prostatic pain?. Eur Urol. 2000 Oct. 38(4):393-9. [Medline].
Giannantoni A, Mearini E, Del Zingaro M, Proietti S, Porena M. Two-year efficacy and safety of botulinum a toxin intravesical injections in patients affected by refractory painful bladder syndrome. Curr Drug Deliv. 2010 Jan 1. 7(1):1-4. [Medline].
Liu HT, Kuo HC. Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis. Urology. 2007 Sep. 70(3):463-8. [Medline].
Gupta M, Patel T, Xavier K, Maruffo F, Lehman D, Walsh R. Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. J Urol. 2010 Feb. 183(2):598-602. [Medline].
Davies J, Duffy D, Boyt N, Aghahoseini A, Alexander D, Leveson S. Botulinum toxin (botox) reduces pain after hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum. 2003 Aug. 46(8):1097-102. [Medline].
Hawley PH. Botulinum toxin for severe anorectal pain. J Pain Symptom Manage. 2002 Jul. 24(1):11-3. [Medline].
Patti R, Almasio PL, Arcara M, et al. Long-term manometric study of anal sphincter function after hemorrhoidectomy. Int J Colorectal Dis. 2007 Mar. 22(3):253-7. [Medline].
Singh B, Box B, Lindsey I, George B, Mortensen N, Cunningham C. Botulinum toxin reduces anal spasm but has no effect on pain after haemorrhoidectomy. Colorectal Dis. 2009 Feb. 11(2):203-7. [Medline].
Patti R, Arcara M, Bonventre S, Sammartano S, Sparacello M, Vitello G. Randomized clinical trial of botulinum toxin injection for pain relief in patients with thrombosed external haemorrhoids. Br J Surg. 2008 Nov. 95(11):1339-43. [Medline].
Abbott J. The use of botulinum toxin in the pelvic floor for women with chronic pelvic pain-a new answer to old problems?. J Minim Invasive Gynecol. 2009 Mar-Apr. 16(2):130-5. [Medline].
Abbott JA, Jarvis SK, Lyons SD, Thomson A, Vancaille TG. Botulinum toxin type A for chronic pain and pelvic floor spasm in women: a randomized controlled trial. Obstet Gynecol. 2006 Oct. 108(4):915-23. [Medline].
Abbott J. Gynecological indications for the use of botulinum toxin in women with chronic pelvic pain. Toxicon. 2009 Oct. 54(5):647-53. [Medline].
Rao A, Abbott J. Using botulinum toxin for pelvic indications in women. Aust N Z J Obstet Gynaecol. 2009 Aug. 49(4):352-7. [Medline].
Van Daele DJ, Finnegan EM, Rodnitzky RL, Zhen W, McCulloch TM, Hoffman HT. Head and neck muscle spasm after radiotherapy: management with botulinum toxin A injection. Arch Otolaryngol Head Neck Surg. 2002 Aug. 128(8):956-9. [Medline].
Vasan CW, Liu C, Klussmann JP, Guntinas-Lichius O. Botulinum toxin type A for the treatment of chronic neck pain after neckdissection. Head & Neck. 2004. 26(1):39-45.
Wittekindt C, Liu WC, Preuss SF, Guntinas-Lichius O. Botulinum toxin A for neuropathic pain after neck dissection: a dose-finding study. Laryngoscope. 2006 Jul. 116(7):1168-71. [Medline].
Silberstein SD, Lipton RB, Solomon S, Mathew N. Classification of daily and near-daily headaches: proposed to the revisions to the IHS criteria. Headache. 1994. 34:1-7.
Binder WJ, Brin MF, Blitzer A, Schoenrock LD, Pogoda JM. Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study. Otolaryngol Head Neck Surg. 2000 Dec. 123(6):669-76. [Medline].
Silberstein S, Mathew N, Saper J, Jenkins S. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group. Headache. 2000 Jun. 40(6):445-50. [Medline].
Brin MF, Swope DM, O’Brien C, et al. BOTOX for migraine: double blind, placebo-controlled, region-specific evaluation. [abstract]. Cephalagia. 2000. 20:421:
Barrientos N, Chana P. Efficacy and safety of botulinum toxin type A (BOTOX) in the prophylactic treatment of migraine. Presented at the American Headache Society 44th Annual Scientific Meeting. Seattle, WA, 2002.
Eross EG, Dodick DW. The effects of botulinum toxin type A on disability in episodic and chronic migraine. Presented at the American Headache Society 44th Annual Scientific Meeting, Seattle, WA, 2002.
Mathew NT, Kallasam J, Kaupp A, et al. "Disease modification" in chronic migraine with botulinum toxin type A: long-term experience. Presented at the American Headache Society 44th Annual Scientific Meeting, Seattle, WA, 2002.
Mauskop A. The use of botulinum toxin in the treatment of headaches. Curr Pain Headache Rep. 2002 Aug. 6(4):320-3. [Medline].
Blumenfeld A. Botulinum toxin type A (Botox) as an effective prophylactic treatment in headache [abstract 81]. Presented at the 6th headache Congress, European Headache Federation, Istanbul, Turkey, June 26-30, 2002.
Mauskop A. Long-term use of botulinum toxin type A (BOTOX) in the treatment of episodic and chronic migraine headaches. Presented at the American Headache Society 44th Annual Scientific Meeting, Seattle, WA, 2002a.
Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache. 1982 Mar. 22(2):66-8. [Medline].
Miller T, Denny L. Retrospective cohort analysis of 48 chronic headache patients treated with botulinum toxin type A (Botox) in a combination fixed-injection-site and "follow the pain" protocol [abstract S138]. Presented at the American Headache Society’s 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002.
Dodick D, Blumenfeld A, Silberstein SD. Botulinum neurotoxin for the treatment of migraine and other primary headache disorders. Clin Dermatol. 2004 Jan-Feb. 22(1):76-81. [Medline].
Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol. 1997. 4(suppl 2):S71-4.
Saper JR, Mathew NT, Loder EW, DeGryse R, VanDenburgh AM,. A double-blind, randomized, placebo-controlled comparison of botulinum toxin type a injection sites and doses in the prevention of episodic migraine. Pain Med. 2007 Sep. 8(6):478-85. [Medline].
Elkind AH, O’Carroll CP, Blumenfeld A, DeGryse R, Dimitrova R. A randomized, controlled, 3-study series of multiple treatments with low doses of botulinum toxin type A for the prophylaxis of episodic migraine. American Headache Society [abstract] 2002; June 18-20; Philadelphia, PA.
Jakubowski M, McAllister PJ, Bajwa ZH, Ward TN, Smith P, Burstein R. Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain. 2006 Dec 5. 125(3):286-95. [Medline]. [Full Text].
Zwart JA, Bovim G, Sand T, Sjaastad O. Tension headache: botulinum toxin paralysis of temporal muscles. Headache. 1994 Sep. 34(8):458-62. [Medline].
Relja M, Poole AC, Schoenen J, Pascual J, Saulay M, Kumar C. A multicenter, double-blind, randomized, placebo-controlled, parallel group study of multiple treatments of botulinum toxin type A (BoNTA) for the prophylaxis of migraine headaches [abstract]. Presented at the European Neurological Society, Vienna, Austria, June 20, 2005.
Wheeler AH. Botulinum toxin injection technique for treatment of headaches. Aesthet Surg J. 2002 Jan. 22(1):65-8. [Medline].
Schulte-Mattler WJ, Wieser T, Zierz S. Treatment of tension-type headache with botulinum toxin: a pilot study. Eur J Med Res. 1999 May 26. 4(5):183-6. [Medline].
Freund BJ, Schwartz M. Treatment of whiplash associated neck pain [corrected] with botulinum toxin-A: a pilot study. J Rheumatol. 2000 Feb. 27(2):481-4. [Medline].
Smuts JA, Barnard PWA. Botulinum toxin A in the treatment of headache syndromes: a clinical report of 79 patients. Cephalalgia. 2000. 20:\:332.
Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of tension-type headache. Curr Rev Pain. 2000. 4(1):31-5. [Medline].
Smuts JA, Baker MK, Wieser T, et al. Treatment of tension-type headache using botulinum toxin type A. Eur J Neurol. 1999. 6(Suppl 4):S99-102.
Gobel H, Lindner V, Krack PK, et al. Treatment of chronic tension-type headache with botulinum toxin. [abstract]. Cephalagia. 1999. 19;455:
Rollnik JD, Tanneberger O, Schubert M, Schneider U, Dengler R. Treatment of tension-type headache with botulinum toxin type A: a double-blind, placebo-controlled study. Headache. 2000 Apr. 40(4):300-5. [Medline].
Schmitt WJ, Slowey E, Fravi N, Weber S, Burgunder JM. Effect of botulinum toxin A injections in the treatment of chronic tension-type headache: a double-blind, placebo-controlled trial. Headache. 2001 Jul-Aug. 41(7):658-64. [Medline].
Ginies PR, Fraimount JL, et al. Treatment of cluster headache by subcutaneous injection of botulinum toxin [absract]. In: Jensen TS, editor. Progress in Pain Research and Management. Seattle: IASP Press,1996:501.
Freund BJ, Schwartz M. The use of botulinum toxin A in the treatment of refractory cluster headache: case reports. Cephalagia. 2000. 20:329-30.
Robbins L. Botulinum toxin for cluster headache. Presented at the 10th Congress of the International Headache Society, New York, NY, 2001.
Scher AI, Stewart WF, Lieberman J, Lipton RB. Prevalence of frequent headache in a population sample. Headache. 1998. 38:497-506.
Goadsby PJ, Silberstein SD, Dodick DW, eds. Chronic daily headache for clinicians London, UK: BC Decker Inc: 2005.
Wheeler AH. Botulinum toxin A, adjunctive therapy for refractory headaches associated with pericranial muscle tension. Headache. 1998 Jun. 38(6):468-71. [Medline].
Spierings EL, Schroevers M, Honkoop PC, Sorbi M. Development of chronic daily headache: a clinical study. Headache. 1998 Jul-Aug. 38(7):529-33. [Medline].
Klapper JA, Klapper A. Use of botulinum toxin in chronic daily headaches associated with migraine. Headache. 1999. 10:141-3.
Argoff CE. A focused review on the use of botulinum toxins for neuropathic pain. Clin J Pain. 2002 Nov-Dec. 18(6 Suppl):S177-81. [Medline].
Ondo WF, Vuong KD, Derman HS. Botulinum toxin A (Botox) for chronic daily headache: a randomized placebo-controlled, parallel design study [abstract S131]. Presented at the American Headache Society’s 44th Annual Scientific Meeting, Seattle, WA, June 21-23, 2002.
Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C. Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Headache. 2005 Apr. 45(4):293-307. [Medline].
Silberstein SD, Stark SR, Lucas SM, et al. Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial. Mayo Clin Proc. 2005 Sep. 80(9):1126-37. [Medline].
Elkind AH, Turkel CC. Botulinum toxin type A for the prophylaxis of headache in migraineurs with 16 or more days of headache per 30-days: effect on the frequency of all headache attacks & headaches of >/= 4 hour in duration (randomized, double-blind, placebo-controlled study) [abstract]. Presented at the European Neurological Society, Vienna, Austria., June 20, 2005.
Freitag FG, McAllister P, Freund B, et al. Botulinum toxin type A for the prophylaxis of chronic daily headache in migraineurs: effect on acute headache pain medication use [abstract]. Presented at the European Neurological Society, Vienna, Austria, June 21, 2005.
Frishberg BM, Mathew T, Gawel M, DeGryse R, Turkel C. Botulinum toxin type A for the prophylaxis of chronic daily headache (CDH) in migraineurs: a randomized, double-blind, placebo-controlled trial [abstract]. Presented at the American Headache Society‘s 47th Annual Scientific Meeting, Philadelphia, PA, June 18-20, 2005.
Dodick DW, Mauskop A, Elkind AH, et al. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study. Headache. 2005 Apr. 45(4):315-24. [Medline].
Aurora SK, VanDenburgh AM. Botulinum toxin type A for the prophylaxis of chronic daily headache in migraineurs: effect on the frequency of headaches of >4 hours duration (a randomized, double-blind, placebo-controlled study). Presented at the American Headache Society‘s 47th Annual Scientific Meeting. Philadelphia, PA, June 18-20, 2005.
Evers S, Rahmann A, Vollmer-Haase J, Husstedt IW. Treatment of headache with botulinum toxin A--a review according to evidence-based medicine criteria. Cephalalgia. 2002 Nov. 22(9):699-710. [Medline].
Evers S. Is there a role for botulinum toxin in the treatment of migraine?. Curr Pain Headache Rep. 2003. 7(3):229-34.
Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache. 1997 Apr. 37(4):253-5. [Medline].
Stillman M, Cherian N, Oas S, Elchami Z, Mays MA. Botulinum toxin, type A. (BoNT-A) for the treatment of cervicalgia and cervicogenic headache: results for single center, randomized, double-blind, active placebo-controlled trial [abstract P06.189]. Presented at the American Academy of Neurology’s 58th Annual Meeting, San Diego, CA, April 1-8, 2006.
Galvez-Jimenez N, Lampuri C, Patino-Picirrillo R, Hargreave MJ, Hanson MR. Dystonia and headaches: clinical features and response to botulinum toxin therapy. Adv Neurol. 2004. 94:321-8. [Medline].
Freund B, Schwartz M, Symington JM. Botulinum toxin: new treatment for temporomandibular disorders. Br J Oral Maxillofac Surg. 2000 Oct. 38(5):466-71. [Medline].
von Lindern JJ, Niederhagen B, Berge S, Appel T. Type A botulinum toxin in the treatment of chronic facial pain associated with masticatory hyperactivity. J Oral Maxillofac Surg. 2003 Jul. 61(7):774-8. [Medline].
Nixdorf DR, Heo G, Major PW. Randomized controlled trial of botulinum toxin A for chronic myogenous orofacial pain. Pain. 2002 Oct. 99(3):465-73. [Medline].
Kim C, McCall WD Jr, Kim YK, Chung JW. Effect of botulinum toxin on pressure pain threshold and EMG power spectrum of masseter muscle during sustained fatiguing contraction. Am J Phys Med Rehabil. 2010 Sep. 89(9):736-43. [Medline].
Taylor M, Silva S, Cottrell C. Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study. Headache. 2008 Nov-Dec. 48(10):1476-81. [Medline].
Kapural L, Stillman M, Kapural M, McIntyre P, Guirgius M, Mekhail N. Botulinum toxin occipital nerve block for the treatment of severe occipital neuralgia: a case series. Pain Pract. 2007 Dec. 7(4):337-40. [Medline].
Bigal ME, Lipton RB. The differential diagnosis of chronic daily headaches: an algorithm-based approach. J Headache Pain. 2007 Oct. 8(5):263-72. [Medline]. [Full Text].
Blumenfeld AM, Binder W, Silberstein SD, Blitzer A. Procedures for administering botulinum toxin type A for migraine and tension-type headache. Headache. 2003 Sep. 43(8):884-91. [Medline].
Wheeler AH, Goolkasian P, Gretz SS. Botulinum toxin A for the treatment of chronic neck pain. Pain. 2001 Dec. 94(3):255-60. [Medline].
Acquadro MA, Borodic GE. Treatment of myofascial pain with botulinum A toxin. Anesthesiology. 1994 Mar. 80(3):705-6. [Medline].
Applegate WV. Abdominal cutaneous nerve entrapment syndrome. Surgery. 1972 Jan. 71(1):118-24. [Medline].
Aprill C, Bogduk N. The prevalence of cervical zygapophyseal joint pain. A first approximation. Spine. 1992 Jul. 17(7):744-7. [Medline].
Aprill C, Dwyer A, Bogduk N. Cervical zygapophyseal joint pain patterns. II: A clinical evaluation. Spine. 1990 Jun. 15(6):458-61. [Medline].
Auld AW, Maki-Jokela A, Murdoch DM. Intraspinal narcotic analgesia in the treatment of chronic pain. Spine. 1985 Oct. 10(8):777-81. [Medline].
Badgley CE. The articular facets in relation to low back pain and sciatic radiation. Br J Bone Joint Surg. 1941. 23:481-496.
Beliveau P. A comparison between epidural anaesthesia with and without corticosteroid in the treatment of sciatica. Rheumatol Phys Med. 1971 Feb. 11(1):40-3. [Medline].
Berry FR. Analgesia in patients with fractured shaft of femur. Anaesthesia. 1977 Jun. 32(6):576-7. [Medline].
Blersch W, Schulte-Mattler WJ, Przywara S, May A, Bigalke H, Wohlfarth K. Botulinum toxin A and the cutaneous nociception in humans: a prospective, double-blind, placebo-controlled, randomized study. J Neurol Sci. 2002 Dec 15. 205(1):59-63. [Medline].
Bogduk N. Zygapophysial blocks and epidural steroids. Neural Blockade in Clinical Anaesthesia and Management of Pain. 1988. 935.
Bogduk N, Aprill C, Derby R. Diagnostic blocks of spinal synovial joints. Spine Care: Diagnosis and Conservative Treatment. 1995. 298-321.
Bogduk N, Aprill C, Derby R. Epidural steroid injections. Spine Care: Diagnosis and Conservative Treatment. 1995. 332-42.
Bogduk N, Christophidis N, Cherry D. Epidural use of steroids in the management of back pain and sciatica of spinal origin. Canaberra Australia. Report of the Working Party on Epidural Use of Steroids in the Management of Back. 1993.
Bogduk N, Long DM. Percutaneous lumbar medial branch neurotomy: a modification of facet denervation. Spine. 1980 Mar-Apr. 5(2):193-200. [Medline].
Bogduk N, Marsland. On the concept of third occipital headache. J Neurol Neurosurg Psychiatry. 1986 Jul. 49(7):775-80. [Medline].
Bogduk N, Twomey LT. Clinical anatomy of the lumbar spine. 1991.
Bogduk N, Valencia F. Innervation and pain patterns of the thoracic spine. Physical Therapy of the Neck and Thoracic Spine. 1998. 27.
Bohr T. Problems with myofascial pain syndrome and fibromyalgia syndrome. Neurology. 1996 Mar. 46(3):593-7. [Medline].
Bonica J, Buckley C, Monica G, Murphy TM. Neurolytic blockade and hypophysectomy. Bonica JJ, ed. The Management of Pain. Philadelphia: Lea Febiger; 1990. 1980-2039.
Bonica JJ. Causalgia and other reflex sympathetic dystrophies. Bonica JJ, ed. The Management of Pain. Philadelphia: Lea & Febiger; 1990. 220-43.
Bonica TT, Buckley FO. Regional anesthesia with local anesthetics. The Management of Pain. 1990. 1883-1966.
Brands E, Callanan VI. Continuous lumbar plexus block--analgesia for femoral neck fractures. Anaesth Intensive Care. 1978 Aug. (3):256-8. [Medline].
Brevik H, Hesla PE, Molnar I, et al. Treatment of chronic low back pain and sciatica: comparison of caudal epidural injections of bupivacaine and methylprednisolone with bupivacaine followed by saline. Bonica JJ, Albe-Fessard DL. Advances in Pain Research and Therapy. 1976. 1: 927.
Bridenbaugh PO, DuPen SL, Moore DC, et al. Postoperative intercostal nerve block analgesia versus narcotic analgesia. Anesth Analg. 1973 Jan-Feb. 52(1):81-5. [Medline].
Brown DL. Atlas of Regional Anesthesia. 1992.
Buckley FP, Duval Neto G, Fink BR. Acid and alkaline solutions of local anesthetics: duration of nerve block and tissue pH. Anesth Analg. 1985 May. 64(5):477-82. [Medline].
Burn JM, Langdon L. Duration of action of epidural methyl prednisolone. A study in patients with the lumbosciatic syndrome. Am J Phys Med. 1974 Feb. 53(1):29-34. [Medline].
Bush K, Hillier S. A controlled study of caudal epidural injections of triamcinolone plus procaine for the management of intractable sciatica. Spine. 1991 May. 16(5):572-5. [Medline].
Carette S, Marcoux S, Truchon R. A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med. 1991 Oct 3. 325(14):1002-7. [Medline].
Carrera GF. Lumbar facet joint injection in low back pain and sciatica: preliminary results. Radiology. 1980 Dec. 137(3):665-7. [Medline].
Catchlove RF, Braha R. The use of cervical epidural nerve blocks in the management of chronic head and neck pain. Can Anaesth Soc J. 1984 Mar. 31(2):188-91. [Medline].
Chan ST, Leung S. Spinal epidural abscess following steroid injection for sciatica. Case report. Spine. 1989 Jan. 14(1):106-8. [Medline].
Chutorian A, Root L. Management of spasticity in with botulinum-A toxin. Int Pediatr. 1994. 9:1:35-43.
Cicala RS, Westbrook L, Angel JJ. Side effects and complications of cervical epidural steroid injections. J Pain Symptom Manage. 1989 Jun. 4(2):64-6. [Medline].
Colding A. The effect of regional sympathetic blocks in the treatment of herpes zoster. Acta Anaesthesiol. 1969. 13:133.
Covino B. Neural blockade in clinical anesthesia and management of pain. Clinical Pharmacology of Local Anesthetic Agents. 2nd ed. 1988. 111-144.
Crawford ED, Skinner DG. Intercostal nerve block with thoracoabdominal and flank incisions. Urology. 1982 Jan. 19(1):25-8. [Medline].
Cuckler JM, Bernini PA, Wiesel SW, et al. The use of epidural steroids in the treatment of lumbar radicular pain. A prospective, randomized, double-blind study. J Bone Joint Surg Am. 1985 Jan. 67(1):63-6. [Medline].
Czarski Z. [Treatment of sciatica with hydrocortisone and novocaine injections into the sacral hiatus]. Przegl Lek. 1965. 21(7):511-3. [Medline].
Dan K, Higa K, Tanaka K. Herpetic pain and cellular immunity. Current Topics in Pain Research and Therapy. 1983. 293-305.
Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress ectopic neural discharge originating in experimental neuromas. Pain. 1985 Jun. 22(2):127-37. [Medline].
Dilke TF, Burry HC, Grahame R. Extradural corticosteroid injection in management of lumbar nerve root compression. Br Med J. 1973 Jun 16. 2(867):635-7. [Medline].
Doherty M. Introduction to examination. Rheumatology Examination and Injection Techniques. 1993. 1-19.
Dory MA. Arthrography of the cervical facet joints. Radiology. 1983 Aug. 148(2):379-82. [Medline].
Dougherty JH Jr, Fraser RA. Complications following intraspinal injections of steroids. Report of two cases. J Neurosurg. 1978 Jun. 48(6):1023-5. [Medline].
Drewes A, Jennum P. Epidemiology of myofascial pain, low back pain, morning stiffness and sleep related complaints in the general population. J Musculoske Pain. 1995. 3 (supp 1):68.
Dussault RG, Nicolet VM. Cervical facet joint arthrography. J Can Assoc Radiol. 1985 Mar. 36(1):79-80. [Medline].
Dwyer A, Aprill C, Bogduk N. Cervical zygapophyseal joint pain patterns. I: A study in normal volunteers. Spine. 1990 Jun. 15(6):453-7. [Medline].
Engberg G. Single-dose intercostal nerve blocks with etidocaine for pain relief after upper abdominal surgery. Preliminary communication. Acta Anaesthesiol Scand Suppl. 1975. 60:43-9. [Medline].
Fernandez-de-las-Penas C, Arendt-Nielsen L, Simons DG. Exploding vs. imploding headache in migraine prophylaxis with Botulinum Toxin A. Pain. 2007 Jun. 129(3):363-4; author reply 364-5. [Medline].
Fishbain DA, Goldberg M, Meagher BR, et al. Male and female chronic pain patients categorized by DSM-III psychiatric diagnostic criteria. Pain. 1986 Aug. 26(2):181-97. [Medline].
Fisher RH. Correspondence. J Bone Joint Surg. 1986. 68A:789.
Francis J, You S, Satorius A, Ardila MC, Li Z, Wu G, et al. Subcutaneous botulinum neurotoxin type A and inhibits streptozotoxin-induced chronic pain in a rat model of peripheral diabetic neuropathy [abstract P06.190]. Presented at the American Academy of Neurology’s 58th Annual Meeting, San Diego, CA, April 1-8, 2006.
Freund BJ, Schwartz M. A focal dystonia model for subsets of chronic tension headache. [abstract]. Cephalagia. 2000. 20:433:
Freund BJ, Schwartz M. Treatment of chronic cervical-associated headache with botulinum toxin A: a pilot study. Headache. 2000 Mar. 40(3):231-6. [Medline].
Fricton JR, Kroening R, Haley D, Siegert R. Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. Oral Surg Oral Med Oral Pathol. 1985 Dec. 60(6):615-23. [Medline].
Galindo A. pH-adjusted local anesthetics: clinical experience. Reg Anesth. 1983. 8:35.
Gardner WJ, Goebert HW, Sehgal AD. Intraspinal corticosteroids in the treatment of sciatica. Trans Am Neurol Assoc. 1961. 86:214-5. [Medline].
Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, double-blind evaluation of trigger-point injection therapy for low-back pain. 1989 Sep. 14(9):962-4. [Medline].
Gerwin RD. A study of 96 subjects examined both for fibromyalgia and myofascial pain. J Musculoskeletal Pain. 1995. 3(suppl 1):121.
Ghormley RK. Low back pain with special reference to articular facets with presentation of an operative procedure. JAMA. 1993. 101:1773-1777.
Gloucke CR, Graziotti P. Extradural abscess following local anaesthetic and steroid injection for chronic low back pain. Br J Anesth. 1990. 35:515.
Goebert HW, Jallo JS, Gardner WJ, et al. Painful radiculopathy treated with epidural injections of procaine and hydrocortisone acetate: results in 113 patients. Anesth Analg. 1961. 140:130.
Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA. 2004 Nov 17. 292(19):2388-95. [Medline].
Goldwait JE. The lumbosacral articulation: an explanation of many cases of lumbago, sciatica and paraplegia. Botson Med Surg J. 1911. 164:365-372.
Hickey RF, Tregonning GD. Denervation of spinal facet joints for treatment of chronic low back pain. N Z Med J. 1977 Feb 9. 85(581):96-9. [Medline].
Hobson DE, Gladish DF. Botulinum toxin injection for cervicogenic headache. Headache. 1997 Apr. 37(4):253-5. [Medline].
Hove B, Gyldensted C. Cervical analgesic facet joint arthrography. Neuroradiology. 1990. 32(6):456-9. [Medline].
Humphreys CF, Day M. The control of postoperative pain with the use of bupivicaine injections. J Urol. 1976. 122:506.
Jackson RP. The facet syndrome. Myth or reality?. Clin Orthop. 1992 Jun. (279):110-21. [Medline].
Jackson RP, Jacobs RR, Montesano PX. 1988 Volvo award in clinical sciences. Facet joint injection in low-back pain. A prospective statistical study. Spine. 1988 Sep. 13(9):966-71. [Medline].
Jacobs S, Pullan PT, Potter JM. Adrenal suppression following extradural steroids. Anaesthesia. 1983 Oct. 38(10):953-6. [Medline].
Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med. 1991 Apr 25. 324(17):1186-94. [Medline].
Jankovic J, Schwartz K. Botulinum toxin injections for cervical dystonia. Neurology. 1990 Feb. 40(2):277-80. [Medline].
Jankovic J, Schwartz K, Donovan DT. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug. 53(8):633-9. [Medline]. [Full Text].
Johansson A, Hao J, Sjolund B. Local corticosteroid application blocks transmission in normal nociceptive C-fibres. Acta Anaesthesiol Scand. 1990 Jul. 34(5):335-8. [Medline].
Kirkpatrick AF. The use of epidural steroids in the treatment of lumbar radicular pain [letter]. J Bone Joint Surg [Am]. 1990 Jul. 72(6):948-9. [Medline].
Kirno K, Lindell K. Intercostal nerve blockade. Br J Anaesth. 1986 Feb. 58(2):246. [Medline].
Klapper JA, Mathew NT, Klapper A. Botulinum toxin type A (BTX-A) for the prophylaxis of chronic daily headache. [abstract]. Cephalagia. 2000. 20:292-3.
Klenerman L, Greenwood R, Davenport HT. Lumbar epidural injections in the treatment of sciatica. Br J Rheumatol. 1984 Feb. 23(1):35-8. [Medline].
Knusel B, DeGryse R, Grant M, et al. Intramuscular injection of botulinum toxin type A (Botox) in chronic low back pain associated with muscle spasm [poster abstract]. San Diego, Calif. American Pain Society. Nov 1998.
Korbon GA, Rowlingson JC, Carron H. Correspondence. J Bone Joint Surg. 1986. 68A:788.
Kramer HH, Angerer C, Erbguth F, Schmelz M, Birklein F. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin. J Neurol. 2003 Feb. 250(2):188-93. [Medline].
Lau LS, Littlejohn GO, Miller MH. Clinical evaluation of intra-articular injections for lumbar facet joint pain. Med J Aust. 1985 Dec 9-23. 143(12-13):563-5. [Medline].
Lewinnek GE, Warfield CA. Facet joint degeneration as a cause of low back pain. Clin Orthop. 1986 Dec. (213):216-22. [Medline].
Lilius G, Laasonen EM, Myllynen P. Lumbar facet joint syndrome. A randomised clinical trial. J Bone Joint Surg [Br]. 1989 Aug. 71(4):681-4. [Medline].
Lindholm R, Saleinius P. Caudal, epidural administration of anaesthetics and corticosteroids in the treatment of low back pain. Acta Orthop Scand. 1964. 1:114.
Lippitt AB. The facet joint and its role in spine pain. Management with facet joint injections. Spine. 1984 Oct. 9(7):746-50. [Medline].
Lofstrom B, Wennberg A, Wien L. Late disturbances in nerve function after block with local anaesthetic agents. An electroneurographic study. Acta Anaesthesiol Scand. 1966. 10(2):111-22. [Medline].
Lofstrom JB, Cousins MJ. Sympathetic neural blockade of upper and lower extremity. Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Aanesthesia and Management of Pain. Philadelphia: 1988. 461-502.
Lord SM, Barnsley L, Wallis BJ. Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med. 1996 Dec 5. 335(23):1721-6. [Medline].
Lynch MC, Taylor JF. Facet joint injection for low back pain. A clinical study. J Bone Joint Surg [Br]. 1986 Jan. 68(1):138-41. [Medline].
Mahowald ML, Singh JA, Dykstra D. Long term effects of intra-articular botulinum toxin A for refractory joint pain. Neurotox Res. 2006 Apr. 9(2-3):179-88. [Medline].
Mandl F. Aqueous solution of phenol as a substitute for alcohol in sympathetic block. J Int Col Surg. 1950. 13:566.
Mathews JA, Mills SB, Jenkins VM, et al. Back pain and sciatica: controlled trials of manipulation, traction, sclerosant and epidural injections. Br J Rheumatol. 1987 Dec. 26(6):416-23. [Medline].
McCarron RF, Wimpee MW, Hudkins PG. The inflammatory effect of nucleus pulposus. A possible element in the pathogenesis of low-back pain. Spine. 1987 Oct. 12(8):760-4. [Medline].
Meyers RR, Katz J. Neural pathology of neurolytic and semidestructive agents. Cousins MJ, Bridenbaugh PO, eds. Neural Blockade in Clinical Anesthesia and Management of Pain. 2nd ed. Philadelphia: 1988. 1031-51.
Mooney V, Robertson J. The facet syndrome. Clin Orthop. 1976 Mar-Apr. (115):149-56. [Medline].
Moran R, O'Connell D, Walsh MG. The diagnostic value of facet joint injections. Spine. 13(12):1407-10. [Medline].
Mount HT. Hydrocortisone in the treatment of intervertebral disc protrusion. Can Med Assoc J. 1971 Dec 18. 105(12):1279-80. [Medline].
Mount HTR. Epidural injection of hydrocortisone in the treatment of intervertebral disc protrusion. Current Controversies in Neurosurgery. 1976. 67.
Murphy DF. Intercostal nerve blockade for fractured ribs and postoperative analgesia. Description of a new technique. Reg Anesth. 1983. 8:151.
Murtagh FR. Computed tomography and fluoroscopy guided anesthesia and steroid injection in facet syndrome. Spine. 1988 Jun. 13(6):686-9. [Medline].
O'Brien CF. Clinical applications of botulinum toxin: implications for pain management. Pain Digest. 1998. 8:342-5.
O'Kelly E, Garry B. Continuous pain relief for multiple fractured ribs. Br J Anaesth. 1981 Sep. 53(9):989-91. [Medline].
Opida CL. Evaluation of Myobloc (botulinum toxin type B) in patients with post-whiplash headaches. Presented at the American Academy of Pain Medicine’s 18th annual meeting, San Francisco, CA, 2002b.
Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW, Jensen TS. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology. 2006 Jul 25. 67(2):241-5. [Medline].
Racz GB, Heavner JE, Singleton W, et al. Hypertonic saline and corticosteroid injected epidurally for pain control. Racz GB, ed. Techniques of Neurolysis. Boston: Kluwer Academic Publishers; 1989. 73-86.
Raymond J, Dumas JM. Intraarticular facet block: diagnostic test or therapeutic procedure?. Radiology. 1984 May. 151(2):333-6. [Medline].
Relja M. Treatment of tension-type headache by local injection of botulinum toxin. Eur J Neurol. 1997. 4 (suppl 2):S71-S73.
Relja MA. Treatment of tension-type headache by local of botulinum toxin: 1-year follow-up. Cephalalgia. 2000. 20:336.
Rengachary SS, Watanabe IS, Singer P. Effect of glycerol on peripheral nerve: an experimental study. Neurosurgery. 1983 Dec. 13(6):681-8. [Medline].
Restelli L, Movilia P, Bossi L. Management of pain after thoracotomy: a technique of multiple intercostal nerve blocks [letter]. Anesthesiology. 1984 Sep. 61(3):353-4. [Medline].
Ridley MG, Kingsley GH, Gibson T. Outpatient lumbar epidural corticosteroid injection in the management of sciatica. Br J Rheumatol. 1988 Aug. 27(4):295-9. [Medline].
Robechhi A, Capra R. Lidrocortisone (composto F): prime esperienze cliniche in campo reumatologico. Min Med. 1952. 98:1259.
Ryan MD, Taylor TKF. Management of lumbar nerve-root pain. Med J Aust. 1981. 2:432.
Rydevik D, Holm S, Brown MD, et al. Nutrition of spinal nerve roots: the role of diffusion from the cerebral spinal fluid. Transactions of the 30th Orthopedic Research Society Meeting. 1984. 9:276.
Saal JS, Franson RC, Dobrow R. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Spine. 1990 Jul. 15(7):674-8. [Medline].
Saper JR, Brandes J, Wrubel B, Dodick DW, DeGryse R, VanDenburgh AM. Efficacy of prophylactic treatment with botulinum toxin type A in migraineurs with chronic daily headache overusing acute headache pain medications [abstract]. Presented at the American Headache Society’s 47th Annual Scientific Meeting, Philadelphia, PA, June 18-20, 2005.
Schultz D at ASSIP, Memphis TN. Undefined. December 1-2.
Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002 Nov-Dec. 18(6 Suppl):S198-203. [Medline].
Schwartz M, Freund B. Treatment of temporomandibular disorders with botulinum toxin. Clin J Pain. 2002 Nov-Dec. 18(6 Suppl):S198-203. [Medline].
Sharrock NE. Correspondence. J Bone Joint Surg. 1985. 67A:981.
Shulman M. Treatment of neck pain with cervical epidural steroid injection. Regional Anesth. 1986. 11:92.
Silberstein SD, Olesen J, Bousser MG, et al. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005 Jun. 25(6):460-5. [Medline].
Silvers HR. Lumbar percutaneous facet rhizotomy. Spine. 1990 Jan. 15(1):36-40. [Medline].
Sluijter M. Percutaneous thermal lesions in the treatment of back and neck pain. Radionics Procedure Technique Series. Burlington, Ma: 1981.
Sluijter ME, McMillin JN, Emery ST et al. Intradiscal steroids. A prospective double-blind clinical trial. Spine. 1992. 17S:172-75.
Snoek W, Weber H, Jorgensen B. Double blind evaluation of extradural methyl prednisolone for herniated lumbar discs. Acta Orthop Scand. 1977. 48(6):635-41. [Medline].
Sweet WH, Poletti CE, Macon JB. Treatment of trigeminal neuralgia and other facial pains by retrogasserian injection of glycerol. Neurosurgery. 1981 Dec. 9(6):647-53. [Medline].
Travell J, Simons D. Myofascial pain and dysfunction. The Trigger Point Manual. Baltimore: Williams and Wilkins; 1983.
Tsui JK, Eisen A, Stoessl AJ. Double-blind study of botulinum toxin in spasmodic torticollis. Lancet. 1986 Aug 2. 2(8501):245-7. [Medline].
Tucker GT, Mather LE. Properties, Absorption, and Disposition of Local Anesthetic Agents. 2nd ed. 1988. 47-110.
Voller B, Sycha T, Gustorff B, et al. A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A. Neurology. 2003 Oct 14. 61(7):940-4. [Medline].
Warfield CA. Correspondence. J Bone Joint Surg. 1985. 67A:980.
Wasner G, Backonja MM, Baron R. Traumatic neuralgias: complex regional pain syndromes (reflex sympathetic dystrophy and causalgia): clinical characteristics, pathophysiological mechanisms and therapy. Neurol Clin. 1998 Nov. 16(4):851-68. [Medline].
Watkin H. Back pain--an integrated approach in primary care. Acupunct Med. 2004 Dec. 22(4):203-6. [Medline].
WE MOVE. Practical considerations for the clinical use of botulinum toxin type B: a self-study continuing medical education activity. February, 2002.
Wedel DJ, Wilson PR. Cervical facet arthrography. Reg Anesth. 1985. 10:7.
Wheeler AH. Chronic Daily Headache: Theory to Therapy. Curr Rev Pain. 1999. 3(6):481-488. [Medline].
Wheeler AH. Therapeutic uses of botulinum toxin. Am Fam Physician. 1997 Feb 1. 55(2):541-5. [Medline].
Wheeler AH, Goolkasian P, Gretz SS. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome. Spine (Phila Pa 1976). 1998 Aug 1. 23(15):1662-6; discussion 1667. [Medline].
Wheeler AH, Hanley EN Jr. Nonoperative treatment for low back pain. Rest to restoration. Spine. 1995 Feb 1. 20(3):375-8. [Medline].
Yates DW. A comparison of the types of epidural injection commonly used in the treatment of low back pain and sciatica. Rheumatol Rehabil. 1978 Aug. 17(3):181-6. [Medline].
Yue SK. Initial experience in the use of botulinum toxin A for the treatment of myofascial related muscle dysfunction. J Musculoskeletal Pain. 1995. 3 (suppl 1):22.
Zwart JA, Bovim G, Sand T. Tension headache: botulinum toxin paralysis of temporal muscles. Headache. 1994 Sep. 34(8):458-62. [Medline].
